Wang, C., Tsai, T., & Lee, C. (2024). Regulation of exosomes as biologic medicines: Regulatory challenges faced in exosome development and manufacturing processes. Clinical and translational science, 17(8), e13904-n/a. https://doi.org/10.1111/cts.13904
Chicago Style (17th ed.) CitationWang, Chun‐Kai, Teng‐Huang Tsai, and Chung‐Hsi Lee. "Regulation of Exosomes as Biologic Medicines: Regulatory Challenges Faced in Exosome Development and Manufacturing Processes." Clinical and Translational Science 17, no. 8 (2024): e13904-n/a. https://doi.org/10.1111/cts.13904.
MLA (9th ed.) CitationWang, Chun‐Kai, et al. "Regulation of Exosomes as Biologic Medicines: Regulatory Challenges Faced in Exosome Development and Manufacturing Processes." Clinical and Translational Science, vol. 17, no. 8, 2024, pp. e13904-n/a, https://doi.org/10.1111/cts.13904.